Supply rates slowed slightly due to delays in Johnson & Johnson vaccine production
Federal authorities will distribute about 18.5 million doses of COVID-19 vaccines in the United States this week, down 2.5 million from the week before. This is due to delays in Johnson & Johnson’s vaccine supply, White House spokeswoman Jen Psaki said Thursday.
Speaking at a White House briefing, Psaki said 15.8 million doses of Pfizer / BioNTech and Moderna vaccines will be distributed by the government to all states and territories. In addition, 2.7 million doses will be distributed through pharmacy chains.
More than 21 million doses of all three approved coronavirus vaccines were distributed in the United States last week, including more than 3.5 million doses of the recently approved Johnson & Johnson vaccine. Production of this vaccine is slower than expected and the company will not be able to provide it to Americans this week. Deliveries are expected to resume at the end of March.
More than 123 million doses of vaccines had been distributed in the United States by Tuesday morning, according to the Centers for Disease Control and Prevention, of which 93.7 million doses have already been used for vaccinations.